Búsqueda | Portal de Búsqueda de la BVS Enfermería

1.

ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.

Ledermann, J A; Matias-Guiu, X; Amant, F; Concin, N; Davidson, B; Fotopoulou, C; González-Martin, A; Gourley, C; Leary, A; Lorusso, D; Banerjee, S; Chiva, L; Cibula, D; Colombo, N; Croce, S; Eriksson, A G; Falandry, C; Fischerova, D; Harter, P; Joly, F; Lazaro, C; Lok, C; Mahner, S; Marmé, F; Marth, C; McCluggage, W G; McNeish, I A; Morice, P; Nicum, S; Oaknin, A; Pérez-Fidalgo, J A; Pignata, S; Ramirez, P T; Ray-Coquard, I; Romero, I; Scambia, G; Sehouli, J; Shapira-Frommer, R; Sundar, S; Tan, D S P; Taskiran, C; van Driel, W J; Vergote, I; Planchamp, F; Sessa, C; Fagotti, A.

Ann Oncol ; 35(3): 248-266, 2024 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-38307807

2.

Effectiveness and safety of menopause treatments: pitfalls of available evidence and future research need.

Al Wattar, B H; Rogozinska, E; Vale, C; Fisher, D; Petersen, I; Nicum, S; Bannington, D; Talaulikar, V; Freemantle, N.

Climacteric ; 27(2): 154-158, 2024 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-38275167

3.

OVPSYCH2: A randomized controlled trial of psychological support versus standard of care following chemotherapy for ovarian cancer.

Frangou, E; Bertelli, G; Love, S; Mackean, M J; Glasspool, R M; Fotopoulou, C; Cook, A; Nicum, S; Lord, R; Ferguson, M; Roux, R L; Martinez, M; Butcher, C; Hulbert-Williams, N; Howells, L; Blagden, S P.

Gynecol Oncol ; 162(2): 431-439, 2021 08.

Artículo en Inglés | MEDLINE | ID: mdl-34059348

4.

A phase II randomised, placebo-controlled trial of low dose (metronomic) cyclophosphamide and nintedanib (BIBF1120) in advanced ovarian, fallopian tube or primary peritoneal cancer.

Hall, M R; Dehbi, H-M; Banerjee, S; Lord, R; Clamp, A; Ledermann, J A; Nicum, S; Lilleywhite, R; Bowen, R; Michael, A; Feeney, A; Glasspool, R; Hackshaw, A; Rustin, G.

Gynecol Oncol ; 159(3): 692-698, 2020 12.

Artículo en Inglés | MEDLINE | ID: mdl-33077258

5.

An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib.

Mateo, J; Moreno, V; Gupta, A; Kaye, S B; Dean, E; Middleton, M R; Friedlander, M; Gourley, C; Plummer, R; Rustin, G; Sessa, C; Leunen, K; Ledermann, J; Swaisland, H; Fielding, A; Bannister, W; Nicum, S; Molife, L R.

Target Oncol ; 11(3): 401-15, 2016 06.

Artículo en Inglés | MEDLINE | ID: mdl-27169564

6.

Chemotherapy for colorectal cancer.

Nicum, S; Midgley, R; Kerr, D J.

J R Soc Med ; 93(8): 416-9, 2000 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-10983503

7.

Adenovirus retargeting and systemic delivery.

Seymour, L W; Fisher, K D; Green, N K; Hale, S J; Lyons, M; Mautner, V; Nicum, S; Onion, D; Oupicky, D; Stevenson, M; Ulbrich, K.

Ernst Schering Res Found Workshop ; (43): 107-14, 2003.

Artículo en Inglés | MEDLINE | ID: mdl-12894454

8.

Chemotherapy versus palliative care in non-small cell lung cancer.

Nicum, S; Cullen, M H.

Anticancer Drugs ; 11(8): 603-7, 2000 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-11081450

9.

The role of mitomycin C in the treatment of patients with advanced colorectal cancer resistant to 5-fluorouracil-folinic acid chemotherapy.

Grumett, S A; Archer, V R; Midgley, R; Mulholland, P; Nicum, S; Blewitt, L; Kerr, D J.

Ann Oncol ; 12(4): 575, 2001 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-11398896

Portal de Búsqueda de la BVS Enfermería

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: